Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial
Kirstine Nørregaard Hansen, Michael Maeng, Bent Raungaard, Thomas Engstrøm, Karsten Tange Veien, Steen Dalby Kristensen, Julia Ellert-Gregersen, Svend Eggert Jensen, Anders Junker, Johnny Kahlert, Lars Jakobsen, Evald Høj Christiansen, Lisette Okkels Jensen
Dyk ned i forskningsemnerne om 'Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial'. Sammen danner de et unikt fingeraftryk.